Professor Chantal Mathieu

Gasthuisberg University Hospital, Leuven (Belgium)

Follow

Contributor content

Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease?

Session

Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease?

28 August 2021

ESC 365 is supported by

novartis

Explore sponsored resources